Ondansetron in the prophylaxis of nausea and vomiting induced by cisplatin. 1990

P A van Liessum, and C Seynaeve, and P H de Mulder, and S Kaasa, and E Lane-Allman, and L V Beex, and J Verweij

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D009325 Nausea An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012702 Serotonin Antagonists Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. 5-HT Antagonist,5-HT Antagonists,5-Hydroxytryptamine Antagonist,5-Hydroxytryptamine Antagonists,Antiserotonergic Agent,Antiserotonergic Agents,Serotonin Antagonist,Serotonin Blockader,Serotonin Blockaders,Serotonin Receptor Antagonist,Serotonin Receptor Blocker,Antagonists, 5-HT,Antagonists, 5-Hydroxytryptamine,Antagonists, Serotonin,Serotonin Receptor Antagonists,Serotonin Receptor Blockers,5 HT Antagonist,5 HT Antagonists,5 Hydroxytryptamine Antagonist,5 Hydroxytryptamine Antagonists,Agent, Antiserotonergic,Agents, Antiserotonergic,Antagonist, 5-HT,Antagonist, 5-Hydroxytryptamine,Antagonist, Serotonin,Antagonist, Serotonin Receptor,Antagonists, 5 HT,Antagonists, 5 Hydroxytryptamine,Antagonists, Serotonin Receptor,Blockader, Serotonin,Blockaders, Serotonin,Blocker, Serotonin Receptor,Blockers, Serotonin Receptor,Receptor Antagonist, Serotonin,Receptor Antagonists, Serotonin,Receptor Blocker, Serotonin,Receptor Blockers, Serotonin
D014839 Vomiting The forcible expulsion of the contents of the STOMACH through the MOUTH. Emesis
D017294 Ondansetron A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. 4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-,Zofran ODT,GR-38032F,GR38032F,Ondansetron Hydrochloride,Ondansetron Monohydrochloride,Ondansetron Monohydrochloride Dihydrate,Ondansetron, (+,-)-Isomer,Ondansetron, (R)-Isomer,Ondansetron, (S)-Isomer,SN-307,Zofran,Dihydrate, Ondansetron Monohydrochloride,GR 38032F,Hydrochloride, Ondansetron,Monohydrochloride Dihydrate, Ondansetron,Monohydrochloride, Ondansetron,ODT, Zofran,SN 307,SN307

Related Publications

P A van Liessum, and C Seynaeve, and P H de Mulder, and S Kaasa, and E Lane-Allman, and L V Beex, and J Verweij
January 1989, European journal of cancer & clinical oncology,
P A van Liessum, and C Seynaeve, and P H de Mulder, and S Kaasa, and E Lane-Allman, and L V Beex, and J Verweij
November 1990, The New England journal of medicine,
P A van Liessum, and C Seynaeve, and P H de Mulder, and S Kaasa, and E Lane-Allman, and L V Beex, and J Verweij
September 1997, Zhonghua zhong liu za zhi [Chinese journal of oncology],
P A van Liessum, and C Seynaeve, and P H de Mulder, and S Kaasa, and E Lane-Allman, and L V Beex, and J Verweij
January 1993, European journal of cancer (Oxford, England : 1990),
P A van Liessum, and C Seynaeve, and P H de Mulder, and S Kaasa, and E Lane-Allman, and L V Beex, and J Verweij
November 1997, Zhonghua zhong liu za zhi [Chinese journal of oncology],
P A van Liessum, and C Seynaeve, and P H de Mulder, and S Kaasa, and E Lane-Allman, and L V Beex, and J Verweij
February 1996, Bulletin du cancer,
P A van Liessum, and C Seynaeve, and P H de Mulder, and S Kaasa, and E Lane-Allman, and L V Beex, and J Verweij
June 1994, American journal of hospital pharmacy,
P A van Liessum, and C Seynaeve, and P H de Mulder, and S Kaasa, and E Lane-Allman, and L V Beex, and J Verweij
April 1994, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
P A van Liessum, and C Seynaeve, and P H de Mulder, and S Kaasa, and E Lane-Allman, and L V Beex, and J Verweij
October 1998, Journal of pain and symptom management,
P A van Liessum, and C Seynaeve, and P H de Mulder, and S Kaasa, and E Lane-Allman, and L V Beex, and J Verweij
February 2000, Journal of chemotherapy (Florence, Italy),
Copied contents to your clipboard!